Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Location status: Recruiting
NCT Number: NCT06852950
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Nashville, Tennessee, 37232, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Questionnaire responses regarding patient satisfaction and opinion regarding use of continuous glucose monitoring system: regarding how do subjects feel that using CGM impacted their glucose control on a scale of 1-5, with 1=strongly made it worse, 2=somewhat made it worse, 3=did not make it better or worse, 4=somewhat made it better, and 5=strongly made it better?; regarding what is the overall opinion of subject's experience with CGM use on a scale of 1-5, with 1=very negative, 2=negative, 3=neutral, 4=positive, 5=very positive.
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Questionnaire responses regarding patient satisfaction and opinion regarding quality of diabetes care: regarding how do subjects feel that using CGM impacted the diabetes care overall on a scale of 1-5, with 1=strongly made it worse, 2=somewhat made it worse, 3=did not make it better or worse, 4=somewhat made it better, and 5=strongly made it better.
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Questionnaire responses regarding patient familiarity with continuous glucose monitoring: regarding degree of familiarity of CGMs in general and the different types of information provided by CGMs, what is the subject's familiarity on a scale of 1-5, with 1=very unfamiliar, 2=unfamiliar, 3=neutral, 4=familiar, 5=very familiar.
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Degree of average change in Hemoglobin A1C from start to end of study
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Degree of average change in glucose management indicator (GMI)
Time frame: From enrollment until follow-up telephone visit 2-3 weeks after discharge
Number of participants with 30-day Readmissions Related to Glycemic Control (hyperglycemia, hypoglycemia, or diabetic ketoacidosis)
Contact information is provided by the study sponsor or research team.
Vanderbilt University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06899191
Autoimmune Diseases, Diabetes Mellitus
New Brunswick, New Jersey, United States
View Trial DetailsNCT07574333
Diabetes Mellitus, Diabetes Mellitus, Type 2
Moscow, Russia
View Trial DetailsNCT07195045
Autoimmune Diseases, Diabetes Complications
Pathum Wan, Bangkok, Thailand
View Trial DetailsNCT07086989
Aorta Stenosis, Aortic Coarctation
Budapest, Hungary
View Trial Details